FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoshio Honma

Research Profile

Physiology

Anatomy

Disorders

Living Beings

Mouse

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Takashi Kasukabe; Nobuo Kato; Junko Okabe-Kado; Yu Haranosono; Yoshio Honma
Inhibition of rapamycin-induced Akt phosphorylation by cotylenin A correlates with their synergistic growth inhibition of cancer cells.
Yoshihide Shimojo; Yoshitsugu Tajima; Miho Akimoto; Tsunehiro Hisanaga; Yoshio Honma; Tsuneo Tanaka; Keizo Takenaga
Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells.
Koshi Kawakami; Yuriko Maruyama; Junko Ohkanda; Takeshi Sassa; Junji Suzumiy; Keizo Takenaga; Miki Tongu; Takaya Yamada; Miho Akimoto; Miho Hattori; Takatsugu Inoue; Nobuo Kato; Yoshio Honma
A novel fusicoccin derivative preferentially targets hypoxic tumor cells and inhibits tumor growth in xenografts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoshio Honma (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Takashi Kasukabe; Nobuo Kato; Junko Okabe-Kado; Yu Haranosono; Yoshio Honma
Inhibition of rapamycin-induced Akt phosphorylation by cotylenin A correlates with their synergistic growth inhibition of cancer cells.
International journal of oncology 2013;42(2):767-75.
2013: Yoshihide Shimojo; Yoshitsugu Tajima; Miho Akimoto; Tsunehiro Hisanaga; Yoshio Honma; Tsuneo Tanaka; Keizo Takenaga
Attenuation of reactive oxygen species by antioxidants suppresses hypoxia-induced epithelial-mesenchymal transition and metastasis of pancreatic cancer cells.
Clinical & experimental metastasis 2013;30(2):143-54.
2012: Koshi Kawakami; Yuriko Maruyama; Junko Ohkanda; Takeshi Sassa; Junji Suzumiy; Keizo Takenaga; Miki Tongu; Takaya Yamada; Miho Akimoto; Miho Hattori; Takatsugu Inoue; Nobuo Kato; Yoshio Honma
A novel fusicoccin derivative preferentially targets hypoxic tumor cells and inhibits tumor growth in xenografts.
Anti-cancer agents in medicinal chemistry 2012;12(7):791-800.
2011: Tsutomu Takahashi; Koshi Kawakami; Seiji Mishima; Miho Akimoto; Keizo Takenaga; Junji Suzumiya; Yoshio Honma
Cyclopamine induces eosinophilic differentiation and upregulates CD44 expression in myeloid leukemia cells.
Leukemia research 2011;35(5):638-45.
2010: Koshi Kawakami; Yoshio Honma
[Leukemia inhibitory factor (LIF)].
Nihon rinsho. Japanese journal of clinical medicine 2010;68 Suppl 7():134-6.
2009: Junko Okabe-Kado; Takashi Kasukabe; Yoshio Honma; Hirofumi Kobayashi; Nobuo Maseki; Yasuhiko Kaneko
Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells.
Cancer science 2009;100(10):1885-94.
2009: Junko Okabe-Kado; Takashi Kasukabe; Yoshio Honma; Hirofumi Kobayashi; Nobuo Maseki; Yasuhiko Kaneko
Extracellular NM23-H1 protein inhibits the survival of primary cultured normal human peripheral blood mononuclear cells and activates the cytokine production.
International journal of hematology 2009;90(2):143-52.
2009: H Tsumura; M Akimoto; H Kiyota; Y Ishii; H Ishikura; Yoshio Honma
Gene expression profiles in differentiating leukemia cells induced by methyl jasmonate are similar to those of cytokinins and methyl jasmonate analogs induce the differentiation of human leukemia cells in primary culture.
Leukemia 2009;23(4):753-60.
2008: Takashi Kasukabe; Junko Okabe-Kado; Yoshio Honma
Cotylenin A, a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2.
Cancer science 2008;99(8):1693-8.
2008: Akiyoshi Horie; Miho Akimoto; Hiroto Tsumura; Makoto Makishima; Takeshi Taketani; Seiji Yamaguchi; Yoshio Honma
Induction of differentiation of myeloid leukemia cells in primary culture in response to lithocholic acid acetate, a bile acid derivative, and cooperative effects with another differentiation inducer, cotylenin A.
Leukemia research 2008;32(7):1112-23.
2007: Yoshio Honma; Miho Akimoto
Therapeutic strategy using phenotypic modulation of cancer cells by differentiation-inducing agents.
Cancer science 2007;98(11):1643-51.
2006: Manabu Matsunawa; Yuki Ishii; Takashi Kasukabe; Shigeru Tomoyasu; Hidekazu Ota; Yoshio Honma
Cotylenin A-induced differentiation is independent of the transforming growth factor-beta signaling system in human myeloid leukemia HL-60 cells.
Leukemia & lymphoma 2006;47(4):733-40.
2005: Yoshio Honma; Takashi Kasukabe; Takao Yamori; Nobuo Kato; Takeshi Sassa
Antitumor effect of cotylenin A plus interferon-alpha: possible therapeutic agents against ovary carcinoma.
Gynecologic oncology 2005;99(3):680-8.
2005: Junko Okabe-Kado; Takashi Kasukabe; Yoshio Honma; Ryoji Hanada; Akira Nakagawara; Yasuhiko Kaneko
Clinical significance of serum NM23-H1 protein in neuroblastoma.
Cancer science 2005;96(10):653-60.
2005: Yuki Ishii; Takashi Kasukabe; Yoshio Honma
Immediate up-regulation of the calcium-binding protein S100P and its involvement in the cytokinin-induced differentiation of human myeloid leukemia cells.
Biochimica et biophysica acta 2005;1745(2):156-65.
2005: Yoshio Honma
[LIF (leukemia inhibitory factor)].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 8():123-4.
2005: Yuki Ishii; Takashi Kasukabe; Yoshio Honma
Induction of CCAAT/enhancer binding protein-delta by cytokinins, but not by retinoic acid, during granulocytic differentiation of human myeloid leukaemia cells.
British journal of haematology 2005;128(4):540-7.
2005: Takashi Kasukabe; Junko Okabe-Kado; Nobuo Kato; Takeshi Sassa; Yoshio Honma
Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts.
Breast cancer research : BCR 2005;7(6):R1097-110.
2004: Yuki Ishii; H Kiyota; S Sakai; Yoshio Honma
Induction of differentiation of human myeloid leukemia cells by jasmonates, plant hormones.
Leukemia 2004;18(8):1413-9.
2004: Kimiko Iijima; Yoshio Honma; Nozomi Niitsu
Granulocytic differentiation of leukemic cells with t(9;11)(p22;q23) induced by all-trans-retinoic acid.
Leukemia & lymphoma 2004;45(5):1017-24.
2004: Akihiro Yokoyama; Takuya Yamashita; Eisuke Shiozawa; Atsuko Nagasawa; Junko Okabe-Kado; Tsuyoshi Nakamaki; Shigeru Tomoyasu; Fumihiko Kimura; Kazuo Motoyoshi; Yoshio Honma; Takashi Kasukabe
MmTRA1b/phospholipid scramblase 1 gene expression is a new prognostic factor for acute myelogenous leukemia.
Leukemia research 2004;28(2):149-57.
2003: Yoshio Honma; Yuki Ishii; Takeshi Sassa; Ken-ichi Asahi
Treatment of human promyelocytic leukemia in the SCID mouse model with cotylenin A, an inducer of myelomonocytic differentiation of leukemia cells.
Leukemia research 2003;27(11):1019-25.
2003: Tsuyoshi Nakamaki; Yasuharu Hamano; Jun-Ichi Hisatake; Akihiro Yokoyama; Kei-Ichiro Kawakami; Shigeru Tomoyasu; Yoshio Honma; Phillip Koeffler
Elevated levels of cyclin A1 and A (A2) mRNA in acute myeloid leukaemia are associated with increased survival.
British journal of haematology 2003;123(1):72-80.
2003: Yoshio Honma; Yuki Ishii; Yuri Yamamoto-Yamaguchi; Takeshi Sassa; Ken-ichi Asahi
Cotylenin A, a differentiation-inducing agent, and IFN-alpha cooperatively induce apoptosis and have an antitumor effect on human non-small cell lung carcinoma cells in nude mice.
Cancer research 2003;63(13):3659-66.
2003: Yuri Yamamoto-Yamaguchi; Junko Okabe-Kado; Takashi Kasukabe; Yoshio Honma
Induction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cells.
Anticancer research 2003;23(3B):2537-47.
2002: Yoshio Honma; Yuki Ishii
Differentiation of human myeloid leukemia cells by plant redifferentiation-inducing hormones.
Leukemia & lymphoma 2002;43(9):1729-35.
2002: Yoshio Honma
Cotylenin A--a plant growth regulator as a differentiation-inducing agent against myeloid leukemia.
Leukemia & lymphoma 2002;43(6):1169-78.
2002: Junko Okabe-Kado; Takashi Kasukabe; Yoshio Honma
Expression of cell surface NM23 proteins of human leukemia cell lines of various cellular lineage and differentiation stages.
Leukemia research 2002;26(6):569-76.
2002: Tsuyoshi Nakamaki; Junko Okabe-Kado; Yuri Yamamoto-Yamaguchi; Ken ichiro Hino; Shigeru Tomoyasu; Yoshio Honma; Takashi Kasukabe
Role of MmTRA1b/phospholipid scramblase1 gene expression in the induction of differentiation of human myeloid leukemia cells into granulocytes.
Experimental hematology 2002;30(5):421-9.
2002: Yuki Ishii; Yuko Hori; Shingo Sakai; Yoshio Honma
Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin nucleosides, plant redifferentiation-inducing hormones.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 2002;13(1):19-26.
2001: Yoshio Honma
A novel therapeutic strategy against monocytic leukemia with deoxyadenosine analogs and adenosine deaminase inhibitors.
Leukemia & lymphoma 2001;42(5):953-62.
2001: K Yamada; Yoshio Honma; Ken-ichi Asahi; T Sassa; Ken-ichiro Hino; Shigeru Tomoyasu
Differentiation of human acute myeloid leukaemia cells in primary culture in response to cotylenin A, a plant growth regulator.
British journal of haematology 2001;114(4):814-21.
2001: Yuki Ishii; S Sakai; Yoshio Honma
Pyridinyl imidazole inhibitor SB203580 activates p44/42 mitogen-activated protein kinase and induces the differentiation of human myeloid leukemia cells.
Leukemia research 2001;25(9):813-20.
2001: Yuri Yamamoto-Yamaguchi; Junko Okabe-Kado; Takashi Kasukabe; Yoshio Honma
Induction of differentiation of human myeloid leukemia cells by immunosuppressant macrolides (rapamycin and FK506) and calcium/calmodulin-dependent kinase inhibitors.
Experimental hematology 2001;29(5):582-8.
2001: Yuri Yamamoto-Yamaguchi; K Yamada; Yuki Ishii; Ken-ichi Asahi; Shigeru Tomoyasu; Yoshio Honma
Induction of the monocytic differentiation of myeloid leukaemia cells by cotylenin A, a plant growth regulator.
British journal of haematology 2001;112(3):697-705.
2001: Nozomi Niitsu; Junko Okabe-Kado; M Okamoto; T Takagi; T Yoshida; S Aoki; M Hirano; Yoshio Honma
Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma.
Blood 2001;97(5):1202-10.
2001: N Niitsu; Y Hayashi; K Sugita; Yoshio Honma
Sensitization by 5-aza-2'-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1alpha,25-dihydroxyvitamin D3.
British journal of haematology 2001;112(2):315-26.
2001: Yoshio Honma; Yuki Ishii; Takashi Kasukabe; Junko Okabe-Kado; Yuri Yamamoto-Yamaguchi; T Kakegawa; A Awaya
Induction of differentiation of human myeloid leukemia cells by novel synthetic neurotrophic pyrimidine derivatives.
Experimental hematology 2001;29(2):194-201.
2001: N Niitsu; Y Hayashi; Yoshio Honma
Downregulation of MLL-CBP fusion gene expression is associated with differentiation of SN-1 cells with t(11;16)(q23;p13).
Oncogene 2001;20(3):375-84.
2001: Nozomi Niitsu; Y Ishii; A Matsuda; Yoshio Honma
Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Cancer research 2001;61(1):178-85.
2000: Yoshio Honma; N Niitsu
Vidarabine and 2-deoxycoformycin as antileukemic agents against monocytic leukemia.
Leukemia & lymphoma 2000;39(1-2):57-66.
2000: Nozomi Niitsu; Yuri Yamamoto-Yamaguchi; Takashi Kasukabe; Junko Okabe-Kado; M Umeda; Yoshio Honma
Antileukemic efficacy of 2-deoxycoformycin in monocytic leukemia cells.
Blood 2000;96(4):1512-6.
2000: Nozomi Niitsu; Junko Okabe-Kado; M Nakayama; Naoki Wakimoto; Akiko Sakashita; Nobuo Maseki; Kazuo Motoyoshi; M Umeda; Yoshio Honma
Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.
Blood 2000;96(3):1080-6.
2000: Nozomi Niitsu; Takashi Kasukabe; A Yokoyama; Junko Okabe-Kado; Yuri Yamamoto-Yamaguchi; M Umeda; Yoshio Honma
Anticancer derivative of butyric acid (Pivalyloxymethyl butyrate) specifically potentiates the cytotoxicity of doxorubicin and daunorubicin through the suppression of microsomal glycosidic activity.
Molecular pharmacology 2000;58(1):27-36.
2000: Nozomi Niitsu; M Umeda; Yoshio Honma
Myeloid and monocytoid leukemia cells have different sensitivity to differentiation-inducing activity of deoxyadenosine analogs.
Leukemia research 2000;24(1):1-9.
1999: Nozomi Niitsu; Junko Okabe-Kado; Takashi Kasukabe; Yuri Yamamoto-Yamaguchi; M Umeda; Yoshio Honma
Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma.
Blood 1999;94(10):3541-50.
1999: Y Kanatani; Takashi Kasukabe; Junko Okabe-Kado; Yuri Yamamoto-Yamaguchi; N Nagata; K Motoyoshi; Yoshio Honma
Role of CD14 expression in the differentiation-apoptosis switch in human monocytic leukemia cells treated with 1alpha,25-dihydroxyvitamin D3 or dexamethasone in the presence of transforming growth factor beta1.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1999;10(10):705-12.
1999: Nozomi Niitsu; Yoshio Honma
Adenosine analogs as possible differentiation-inducing agents against acute myeloid leukemia.
Leukemia & lymphoma 1999;34(3-4):261-71.
1999: Yoshio Honma; Yuri Yamamoto-Yamaguchi; Y Kanatani
Vesnarinone and glucocorticoids cooperatively induce G1 arrest and have an anti-tumour effect on human non-small cell lung carcinoma cells grown in nude mice.
British journal of cancer 1999;80(1-2):96-103.
1999: M Makishima; K Shudo; Yoshio Honma
Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells.
Biochemical pharmacology 1999;57(5):521-9.
1998: Junko Okabe-Kado; Takashi Kasukabe; Yoshio Honma
Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia.
Leukemia & lymphoma 1998;32(1-2):19-28.
1998: Nozomi Niitsu; Y Yamaguchi; M Umeda; Yoshio Honma
Human monocytoid leukemia cells are highly sensitive to apoptosis induced by 2'-deoxycoformycin and 2'-deoxyadenosine: association with dATP-dependent activation of caspase-3.
Blood 1998;92(9):3368-75.
1998: Takashi Kasukabe; H Kobayashi; Y Kaneko; Junko Okabe-Kado; Yoshio Honma
Identity of human normal counterpart (MmTRA1b) of mouse leukemogenesis-associated gene (MmTRA1a) product as plasma membrane phospholipid scramblase and chromosome mapping of the human MmTRA1b/phospholipid scramblase gene.
Biochemical and biophysical research communications 1998;249(2):449-55.
1998: Yoshio Honma; H Tobe; M Makishima; A Yokoyama; Junko Okabe-Kado
Induction of differentiation of myelogenous leukemia cells by humulone, a bitter in the hop.
Leukemia research 1998;22(7):605-10.
1998: K Yamada; Ken-ichiro Hino; Shigeru Tomoyasu; Yoshio Honma; N Tsuruoka
Enhancement by bufalin of retinoic acid-induced differentiation of acute promyelocytic leukemia cells in primary culture.
Leukemia research 1998;22(7):589-95.
1998: M Makishima; K Umesono; K Shudo; T Naoe; K Kishi; Yoshio Honma
Induction of differentiation in acute promyelocytic leukemia cells by 9-cis retinoic acid alpha-tocopherol ester (9-cis tretinoin tocoferil).
Blood 1998;91(12):4715-26.
1998: Naoki Wakimoto; A Yokoyama; Junko Okabe-Kado; Naokazu Nagata; Kazuo Motoyoshi; Yoshio Honma
Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
British journal of cancer 1998;77(12):2298-303.
1998: Naoki Wakimoto; A Yokoyama; Y Mukai; Naruo Kuwada; Takuya Yamashita; Takuya Matsumura; Yukitsugu Nakamura; Y Kanatani; Naokazu Nagata; Junko Okabe-Kado; Yoshio Honma; Kazuo Motoyoshi
Elevated expression of differentiation inhibitory factor nm23 mRNA in monoblastic crisis of a patient with chronic myelogenous leukemia.
International journal of hematology 1998;67(3):313-8.
1998: A Yokoyama; Junko Okabe-Kado; Naoki Wakimoto; H Kobayashi; Akiko Sakashita; Nobuo Maseki; Tsuyoshi Nakamaki; K i Hino; Shigeru Tomoyasu; N Tsuruoka; Kazuo Motoyoshi; Naokazu Nagata; Yoshio Honma
Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.
Blood 1998;91(6):1845-51.
1998: Y Kanatani; M Makishima; I Ishikawa; Y Ogasawara; N Kawahara; Kazuo Motoyoshi; Naokazu Nagata; Yoshio Honma
A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3.
Experimental hematology 1998;26(3):198-206.
1998: M Makishima; Junko Okabe-Kado; Yoshio Honma
Growth inhibition and differentiation induction in human monoblastic leukaemia cells by 1alpha-hydroxyvitamin D derivatives and their enhancement by combination with hydroxyurea.
British journal of cancer 1998;77(1):33-9.
1997: Nozomi Niitsu; Yuri Yamamoto-Yamaguchi; Y Kanatani; S Shuto; A Matsuda; M Umeda; Yoshio Honma
Neplanocin A, a potent inhibitor of S-adenosylhomocysteine hydrolase, potentiates granulocytic differentiation of acute promyelocytic leukemia cells induced by all-trans retinoic acid.
Experimental hematology 1997;25(12):1296-303.
1997: Y Kanatani; M Makishima; Ken-ichi Asahi; A Sakurai; N Takahashi; Kazuo Motoyoshi; Naokazu Nagata; Yoshio Honma
Differanisole A, a novel antitumor antibiotic, enhances growth inhibition and differentiation of human myeloid leukemia cells induced by 9-cis retinoic acid.
Biochimica et biophysica acta 1997;1359(1):71-9.
1997: Ken-ichi Asahi; Yoshio Honma; K Hazeki; T Sassa; Y Kubohara; A Sakurai; N Takahashi
Cotylenin A, a plant-growth regulator, induces the differentiation in murine and human myeloid leukemia cells.
Biochemical and biophysical research communications 1997;238(3):758-63.
1997: Nozomi Niitsu; M Umeda; Yoshio Honma
Induction of differentiation of human myeloid leukemia cells by 2'-deoxycoformycin in combination with 2'-deoxyadenosine.
Biochemical and biophysical research communications 1997;238(1):100-6.
1997: M Makishima; Yoshio Honma
Tretinoin tocoferil as a possible differentiation-inducing agent against myelomonocytic leukemia.
Leukemia & lymphoma 1997;26(1-2):43-8.
1997: Takashi Kasukabe; Junko Okabe-Kado; Yoshio Honma
TRA1, a novel mRNA highly expressed in leukemogenic mouse monocytic sublines but not in nonleukemogenic sublines.
Blood 1997;89(8):2975-85.
1997: Nozomi Niitsu; Yuri Yamamoto-Yamaguchi; H Miyoshi; K Shimizu; M Ohki; M Umeda; Yoshio Honma
AML1a but not AML1b inhibits erythroid differentiation induced by sodium butyrate and enhances the megakaryocytic differentiation of K562 leukemia cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1997;8(3):319-26.
1996: M Makishima; Yoshio Honma
Ethacrynic acid and 1 alpha,25-dihydroxyvitamin D3 cooperatively inhibit proliferation and induce differentiation of human myeloid leukemia cells.
Leukemia research 1996;20(9):781-9.
1996: I Goto; Yuri Yamamoto-Yamaguchi; Yoshio Honma
Enhancement of sensitivity of human lung adenocarcinoma cells to growth-inhibitory activity of interferon alpha by differentiation-inducing agents.
British journal of cancer 1996;74(4):546-54.
1996: A Yokoyama; Junko Okabe-Kado; Y Uehara; T Oki; S Tomoyasu; N Tsuruoka; Yoshio Honma
Angelmicin B, a new inhibitor of oncogenic signal transduction, inhibits growth and induces myelomonocytic differentiation of human myeloid leukemia HL-60 cells.
Leukemia research 1996;20(6):491-7.
1996: Yuri Yamamoto-Yamaguchi; M Makishima; Y Kanatani; Takashi Kasukabe; Yoshio Honma
Reversible differentiation of human monoblastic leukemia U937 cells by ML-9, an inhibitor of myosin light chain kinase.
Experimental hematology 1996;24(6):682-9.
1996: M Makishima; Y Kanatani; Yuri Yamamoto-Yamaguchi; Yoshio Honma
Enhancement of activity of 1alpha, 25-dihydroxyvitamin D3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an alpha-tocopherol ester of all-trans retinoic acid.
Blood 1996;87(8):3384-94.
1996: Y Kanatani; Takashi Kasukabe; Junko Okabe-Kado; S Hayashi; Yuri Yamamoto-Yamaguchi; Kazuo Motoyoshi; Naokazu Nagata; Yoshio Honma
Transforming growth factor beta and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1996;7(2):187-96.
1996: S Sato; S Tomoyasu; Junko Okabe-Kado; M Hozumi; N Tsuruoka; S Nakai; M Adachi; Yoshio Honma
Induction of differentiation and enhancement of vincristine sensitivity of human erythroleukemia HEL cells by vesnarinone, a positive inotropic agent.
Experimental hematology 1996;24(1):37-42.
1995: M Makishima; Yuri Yamamoto-Yamaguchi; Yoshio Honma
19-Allylaminoherbimycin A, an analog of herbimycin A that is stable against treatment with thiol compounds or granulocyte-macrophage colony-stimulating factor in human leukemia cells.
Biochimica et biophysica acta 1995;1272(3):199-205.
1995: Junko Okabe-Kado; Takashi Kasukabe; H Baba; T Urano; H Shiku; Yoshio Honma
Inhibitory action of nm23 proteins on induction of erythroid differentiation of human leukemia cells.
Biochimica et biophysica acta 1995;1267(2-3):101-6.
1995: Junko Okabe-Kado; Takashi Kasukabe; M Hozumi; Yoshio Honma; N Kimura; H Baba; T Urano; H Shiku
A new function of Nm23/NDP kinase as a differentiation inhibitory factor, which does not require it's kinase activity.
FEBS letters 1995;363(3):311-5.
1995: Yoshio Honma; Y Matsuo; Y Hayashi; S Omura
Treatment of Philadelphia-chromosome-positive human leukemia in SCID mouse model with herbimycin A, bcr-abl tyrosine kinase activity inhibitor.
International journal of cancer. Journal international du cancer 1995;60(5):685-8.
1994: Yoshio Honma
Acycloguanosine and herbimycin A co-operatively inhibit proliferation and induce erythrodifferentiation of human myeloid leukemia K562 cells.
Leukemia research 1994;18(11):851-4.
1994: S Sato; Yoshio Honma; M Hozumi; Y Hayashi; Y Matsuo; K Shibata; S Omura; K Hino; S Tomoyasu; N Tsuruoka
Effects of herbimycin A and its derivatives on growth and differentiation of Ph1-positive acute lymphoid leukemia cell lines.
Leukemia research 1994;18(3):221-8.
1994: Takashi Kasukabe; Junko Okabe-Kado; M Hozumi; Yoshio Honma
Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
Cancer research 1994;54(2):592-7.
1993: Y Kanatani; Takashi Kasukabe; M Hozumi; K Motoyoshi; N Nagata; Yoshio Honma
Genistein exhibits preferential cytotoxicity to a leukemogenic variant but induces differentiation of a non-leukemogenic variant of the mouse monocytic leukemia Mm cell line.
Leukemia research 1993;17(10):847-53.
1993: Y Kanatani; Yoshio Honma; T Tsuchimochi; Junko Okabe-Kado; Naokazu Nagata; Kazuo Motoyoshi; M Hozumi
Induction of differentiation and growth suppression of myeloid leukemia cells by sera of patients with hematological disorders.
Anticancer research 1993;13(5C):1905-11.
1993: Yoshio Honma; T Nakamaki; N Tsuruoka
[Role of cytokines in differentiation therapy with retinoic acid].
Gan to kagaku ryoho. Cancer & chemotherapy 1993;20(8):1022-7.
1993: M Makishima; Yoshio Honma; M Hozumi; Naokazu Nagata; Kazuo Motoyoshi
Differentiation of human monoblastic leukemia U937 cells induced by inhibitors of myosin light chain kinase and prevention of differentiation by granulocyte-macrophage colony-stimulating factor.
Biochimica et biophysica acta 1993;1176(3):245-9.
1992: Takashi Kasukabe; Junko Okabe-Kado; Yoshio Honma; M Hozumi
Interleukin 4 potentiates the antiproliferative effect of 1 alpha, 25-dihydroxyvitamin D3 on mouse monocytic leukemia cells but antagonizes the antiproliferative effects of interferon alpha, beta and interleukin 6.
Leukemia research 1992;16(12):1191-6.
1992: Yoshio Honma; Takashi Kasukabe; M Hozumi
Control of growth and differentiation of Philadelphia chromosome-positive leukemia cells by tyrosine kinase inhibitors.
The Tohoku journal of experimental medicine 1992;168(2):387-91.
1992: Junko Okabe-Kado; Yoshio Honma; Takashi Kasukabe; M Hozumi
Synthesis of active metabolite(s) from 1 alpha-hydroxyvitamin D3 by human monocytic leukemia cells.
FEBS letters 1992;309(3):399-401.
1992: Yoshio Honma; Junko Okabe-Kado; Takashi Kasukabe; M Hozumi; H Kodama; S Kajigaya; T Suda; Y Miura
Herbimycin A, an inhibitor of tyrosine kinase, prolongs survival of mice inoculated with myeloid leukemia C1 cells with high expression of v-abl tyrosine kinase.
Cancer research 1992;52(14):4017-20.
1992: Junko Okabe-Kado; Takashi Kasukabe; Yoshio Honma; M Hayashi; W J Henzel; M Hozumi
Identity of a differentiation inhibiting factor for mouse myeloid leukemia cells with NM23/nucleoside diphosphate kinase.
Biochemical and biophysical research communications 1992;182(3):987-94.
1992: Yoshio Honma; Takashi Kasukabe; M Hozumi; K Shibata; S Omura
Effects of herbimycin A derivatives on growth and differentiation of K562 human leukemic cells.
Anticancer research 1992;12(1):189-92.
1992: Takashi Kasukabe; Junko Okabe-Kado; Yoshio Honma; M Hozumi; T Matsuda; T Hirano
Characterization of growth inhibitory factors for mouse monocytic leukemia cells.
Leukemia research 1992;16(2):139-44.
1991: Yoshio Honma; Takashi Kasukabe; M Hozumi; H Akimoto; H Nomura
Induction of differentiation of human myeloid leukemia HL-60 cells by novel nonphosphorus alkyl ether lipids.
Lipids 1991;26(12):1445-9.
1991: Takashi Kasukabe; Junko Okabe-Kado; Yoshio Honma; M Hozumi
Interleukin-4 inhibits the differentiation of mouse myeloid leukemia M1 cells induced by dexamethasone, D-factor/leukemia inhibitory factor and interleukin-6, but not by 1 alpha,25-dihydroxyvitamin D3.
FEBS letters 1991;291(2):181-4.
1991: Yoshio Honma; Y Onozuka; Junko Okabe-Kado; Takashi Kasukabe; M Hozumi
Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
Cancer research 1991;51(17):4535-8.
1991: Yoshio Honma; Junko Okabe-Kado; Takashi Kasukabe; M Hozumi; S Kajigaya; T Suda; Y Miura
Induction by some protein kinase inhibitors of differentiation of a mouse megakaryoblastic cell line established by coinfection with Abelson murine leukemia virus and recombinant SV40 retrovirus.
Cancer research 1991;51(17):4649-55.
1991: Junko Okabe-Kado; M Hayashi; Yoshio Honma; M Hozumi; T Tsuruo
Inhibition by erythroid differentiation factor (activin A) of P-glycoprotein expression in multidrug-resistant human K562 erythroleukemia cells.
Cancer research 1991;51(10):2582-6.
1991: Junko Okabe-Kado; Yoshio Honma; M Hayashi; M Hozumi
Effects of transforming growth factor-beta and activin A on vitamin D3-induced monocytic differentiation of myeloid leukemia cells.
Anticancer research 1991;11(1):181-6.
1991: Junko Okabe-Kado; Yoshio Honma; M Hozumi
Inhibition by vitamin D3 of erythroid differentiation of human leukemia line cells induced by transforming growth factor beta or erythroid differentiation factor (activin A).
Leukemia research 1991;15(8):721-6.
1990: Takashi Kasukabe; Yoshio Honma; M Hozumi; H Nomura
Inhibition of proliferation and induction of differentiation of human and mouse myeloid leukemia cells by new ethyleneglycol-type nonphosphorus alkyl ether lipids.
Japanese journal of cancer research : Gann 1990;81(8):807-12.
1990: M Hozumi; M Tomida; Yuri Yamamoto-Yamaguchi; Takashi Kasukabe; Junko Okabe-Kado; Yoshio Honma; M Hayashi
Protein factors that regulate the growth and differentiation of mouse myeloid leukaemia cells.
Ciba Foundation symposium 1990;148():25-33; discussion 33-42.
1989: Junko Okabe-Kado; Yoshio Honma; M Hayashi; M Hozumi
Inhibitory action of transforming growth factor-beta on induction of differentiation of myeloid leukemia cells.
Japanese journal of cancer research : Gann 1989;80(3):228-32.
1989: Yoshio Honma; Junko Okabe-Kado; M Hozumi; Y Uehara; S Mizuno
Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.
Cancer research 1989;49(2):331-4.
1989: T Ikuta; Yoshio Honma; Junko Okabe-Kado; Takashi Kasukabe; M Hozumi
Normal mouse lung tissue produces a growth-inhibitory factor(s) preferential for mouse monocytic leukemia cells.
Cancer immunology, immunotherapy : CII 1989;30(3):139-44.
1988: Junko Okabe-Kado; Takashi Kasukabe; Yoshio Honma; M Hayashi; M Hozumi
Purification of a factor inhibiting differentiation from conditioned medium of nondifferentiating mouse myeloid leukemia cells.
The Journal of biological chemistry 1988;263(22):10994-9.
1988: Yoshio Honma; T Ikuta; Takashi Kasukabe; M Hozumi; T Itoh; H Ogura
Inhibition of proliferation and induction of differentiation of human myeloid leukemia cells by novel nucleoside analogs.
Anticancer research 1988;8(4):695-9.
1988: Takashi Kasukabe; Junko Okabe-Kado; Yoshio Honma; M Hozumi
Purification of a novel growth inhibitory factor for partially differentiated myeloid leukemic cells.
The Journal of biological chemistry 1988;263(11):5431-5.
1988: M Hozumi; Yoshio Honma; Takashi Kasukabe; M Hayashi; Junko Okabe-Kado
Modification by vitamins and nutrients of induction of terminal differentiation of myeloid leukemia cells.
Progress in clinical and biological research 1988;259():131-48.
1987: Takashi Kasukabe; Junko Okabe-Kado; Yoshio Honma; M Hozumi
Production by undifferentiated myeloid leukemia cells of a novel growth-inhibitory factor(s) for partially differentiated myeloid leukemic cells.
Japanese journal of cancer research : Gann 1987;78(9):921-31.